INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Intercure Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$4.46−0.11 (-2.41%)
Close on Oct 19, 2026
Ownership
Who owns Intercure's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Alexander Rabinovich | 16,765,453 | 29.40% | 13D (active) | Mar 2, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Alexander Rabinovich | Chief Executive Officer, Director | 14,755,062 | 26.98% | Apr 20, 2026 |
| Amos Cohen | Chief Financial Officer | 79,947 | 0.15% | Aug 24, 2026 |
| Alon Shmuel Granot | Director | – | – | Apr 20, 2026 |
| Lennie Grinbaum Michelson | Director | 6,743 | 0.01% | Apr 20, 2026 |
| David Salton | Director | – | – | Apr 16, 2026 |
| Gideon Hirschfeld | Director | – | – | Apr 16, 2026 |